Triad Hospitals — UBS Conference 2003
35 slides from Triad Hospitals's conference presentation, Feb 3, 2003
Slide 1: UBS Conference Presentation
UBS Conference Presentation February 3, 2003
Slide 2: Forward-looking statements
This presentation contains forwart looking statements based on current management expectations. Numerous factors including those related to market conditions and those detailed free time-to-time in the Company’ filings with the Securities and Exchange Commission, may cause results to differ material
Slide 3: Contents
Contents Growth Strategy H Response to UBS @ Questions ATriad
Slide 4: Triad's Current Profile
Triad’s Current Profile 49 Hospitals (Including 1 Under Constructio 14 Ambulator Small Cities & Sele 200+ Rural & Small Cit; ATriad
Slide 5: Unique Strategy for Growth
Unique Strategy for Growth Component Execution Growth
Slide 6: Physician Relations Strategy
Physician Relations Strategy @ Physician Leadership Groups — “PLGs” - Local PLG at each hospital - National PLG President on Triad Board (ex officio) - Members are key and influential physicians - Participants include Hospital and Corporate Management - PLGs facilitate robust dialogue, create mutual
Slide 7: Community Relations Strategy
Community Relations Strategy @ Local Boards of Trustees - Community leaders - Local-issues governance authority ATriad
Slide 8: Nursing Relations Strategy
Nursing Relations Strategy @ Nursing Leadership Group — “NLG” - Led by hospitals’ Chief Nursing Officers - Local “grass roots” initiatives - National “best practices” applications ATriad
Slide 9: Capital Strategy
Capital Strategy @ Internal Expansion — Past & Future @ External Development — Future > Several Hospitals Per Year > Mostly Development, Less Acquisition > Focus on Not-for-Profit Partnerships Financial Return Criterion: ROI > Hurdle Rate > WACC. ATriad
Slide 10: Not-for-Profit Partnership Strategy
Not-for-Profit Partnership Strategy @ Contract Management & Consulting (QHR) Contract management for 200 Not-for-Profit hospitals Consulting and education to hospitals Specialized consulting to hospitals in distress @ Capital Partnership Partner with Not-for-Profits - investment, development, acquis
Slide 11: Sources of Growth
Sources of Growth @ Operations } Internal (Past & Future) @ Expansion @ Development . External (Future) @ Not-For-Profit Partnerships ATriad
Slide 12: Growth from Operations
Growth from Operations EBITDA Margin 25% 23% 21% ea 19-6 20.4% " 5% toe 16.8% ‘a 15% 13% 11% 9% MH HCA THC LPNT HMA Mm 22.9% Data is for twelve months ended 9/30/02 for TRI, UHS, CYH, PRV, HCA, LPNT and HMA, and for twelve months ended 8/31/02 for THC. EBITDAR is used for UHS. iad Source: Company re
Slide 13: Growth from Capital
Growth from Capital Capital Expenditures, 2001-2003E (millions) $800 $607 $600 $400 $200 $90 $0 Development
Slide 14: Growth from Capital
Growth from Capital Capital Expenditures, 2001-2003E (millions) $400 $300 $200 $100 $0 2001 2002E 2003E CiMaintenance EExpansion & Development ment ROIC > Hurdle Rate > ¥ Current management estimates, subject to change. 44
Slide 15: Growth from Capital: Developments
Growth from Capital Developments Hospital MountainView Regional (Las Cruces, NM) Mesa View Regional (Mesquite, NV) Summary New 867 mm, 112/172-bed hospital, opened 8/02 Stem outmigration to El Paso, TX Owned and managed by Triad New $30 mm, 30-bed hospital to open 2004 Stem outmigration to St. Georg
Slide 16: Growth from Capital: Potential Developments
Growth from Capital Potential Developments Hospital Summary Fairmont, WV Selected by community Sole community provider in CON state Currently managed by QHR Lease hospital, then build replacement hospital Triad would own and manage ATriad 6 ant
Slide 17: Potential Developments with Not-for-Profit Partners
Growth from Capital Potential Developments with Not-for-Profit Partners Hospital Eugene/Springfield, OR Palmer, AK Erwin, NC Summary Not-for-Profit Partnership with local hospital Triad majority partner, with shared governance JV to own existing hospital & build replacement Not-for-Profit Partnershi
Slide 18: Growth in Earnings Per Share
Growth in Earnings Per Share +20% “180% 420% $2.46-2.70 $2.50 $2.00 $1.78-1.80 $2.08-2.20 $150 $1.00 +135% — +137% . +73% 27 $950 1 gra7ay (0.20 . $0.00 - - = . = ($0.50) ($1.00) $3.00 1998 999 2000 2001 2002E 2003E = 2004E + Company has not changed its earnings guidance since October 22, 2002. +Com
Slide 19: Sources of Growth
Sources of Growth @ Operations } Internal (Past & Future) @ Expansion @ Development . External (Future) @ Not-For-Profit Partnerships ATriad
Slide 20: Response to UBS
Response to UBS @ UBS recently published a new research report on Triad @ We respectfully disagree with UBS’s: e Projected Growth Sources of Growth Strategy for Growth Historic ROIC Impact Access to Capital for Growth Capital Expenditure Contribution e Valuation Cost of Capital @ We appreciate the o
Slide 21: Sources of Growth
Sources of Growth UBS: “Our long-term growth forecast is being cut from 15% to 12%, which assumes a less aggressive sition pace, primarily.
Slide 22: Strategy for Growth
Strategy for Growth UBS: “Company’s business model [is one] of physician recruitment.” ATriad
Slide 23: Historic ROIC Impact
Historic ROIC Impact UBS: “Our concern with Triad is that with a sector low ROIC profile and a less robust balance sheet that its ability to grow may be the most hindered in this more difficult ew mment.” @) Source: Estimates of multiple securities firms (1/03). 23
Slide 24: ROIC from Capital Investment
ROIC from Capital Investment @ Every Triad Project must either: - Generate Positive NPV or be necessary for Maintenance. @ For each non-maintenance Project... - Triad performs Discounted Cash Flow (DCF) Analysis... - Discounting projected Free Cash Flows (FCF)... - At an appropriate Hurdle Rate for
Slide 25: Access to Capital for Growth
Access to Capital for Growth in the group over the past months has TRI from issuing paper to finance growth or improve [its balance sheet].”
Slide 26: Access to Capital: Examples of Unsolicited Quotes
Access to Capital: Examples of Unsolicited Quotes Date May 2002 May 2002 Tune 2002 July 2002 September 2002 October 2002 January 2003 Opportunity Convertible Debt Sr. Sub. Notes Sr. Sub. Notes Convertible Debt Convertible Debt Convertible Debt Sr. Sub. Notes Indicative Rates Indicative Amounts 2.75%
Slide 27: Access To Capital: Bond Trading History
Access To Capital: Bond Trading History Yield to Worst (Lower is Better) 15% 1 DA aie WA Xs 12% U 11% 10% 90 TRI 11% Sr. Sub. Notes 0% 5 as a f [Vin Y WU 6% 1/6/00 7/4/00 12/3100 6/29/01 12/2601 6/2402 12/21/02 Source: Securities firm. Market is securities firm’s High Yield Index. .. a ATriad
Slide 28: Access to Capital: Linked to Strategy
Access to Capital: Linked to Strategy Quality Mission/Value Performance Capital Creating an “Upward Spiral” : “Triad 8
Slide 29: Capital Expenditure Contribution
Capital Expenditure Contribution UBS: Model assumes Capital Expenditures add no Volume, Cash Flow. CapEx of about $300 million per year... yet only 2.3% Volume Growth. ATriad
Slide 30: Valuation: Cost of Capital
Valuation: Cost of Capital Cost Cost Weighted Average of Debt of Equity Cost of Capital 9% (Pretax) 18.5% 12.6% 5.4% (After-Tax) Others © 7.6% (Pretax) 10.3% 4.6% (After-tax) ® Source: Sampling of multiple securities firms (January 2003). These estimates do not represent the views or opinions of Tri
Slide 31: Sensitivity of Target Price to Cost of Capital
Sensitivity of Target Price to Cost of Capital Implied Target Price $200 Sirs $176 $150 $125 $104 $100 = $75 $3 $50. $50 +355 : il a | 12.6% 11.0% 10.0% 9.0% 80% 7.0% Weighted Average Cost of Capital (WACC) Method: Using UBS's cash flows and growth rates (unchanged), Triad mechanically input differe
Slide 32: Recap of Response to UBS
Recap of Response to UBS ™ Projected Growth Sources of Growth Strategy for Growth Historic ROIC Impact Access to Capitat Capital Expenditure @ Valuation Higher From Ops, Internal Expansion, External Development Physician Relations (not Recruitment) Reinforces External Growth Does not restrict Future
Slide 33: Our Past, Present & Future Outlook
Our Past, Present & Future Outlook 1999 - 2000 2001 2002 & Beyond Spin-Off Acquisition Operating Performance Culture Integration Capital Reinvestment Strategy External Developments Portfolio Not-For-Profit Partnerships Balance Sheet Balance Sheet Performance Start Growth ATriad a ant
Slide 34: Hospitals, Inc
HOSPITALS, INC
Slide 35: UBS Conference Presentation
UBS Conference Presentation February 3, 2003